Literature DB >> 1585917

Low-dose cytosine arabinoside as an alternative treatment for acute leukemia in Jehovah's Witnesses.

P M Dainer, C L Knupp, G P Sartiano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1585917     DOI： 10.1002/ajh.2830400219

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

1.  A Jehovah's Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions.

Authors:  Yumi Yamamoto; Akihito Kawashima; Eri Kashiwagi; Kiyoyuki Ogata
Journal:  Case Rep Hematol       Date:  2014-10-02

2.  Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.

Authors:  Anand P Jillella; Martha L Arellano; Leonard T Heffner; Manila Gaddh; Amelia A Langston; Hanna J Khoury; Abhishek Mangoankar; Vamsi K Kota
Journal:  Hematol Rep       Date:  2017-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.